Group B streptococci in the female genital tract.
Vaginal carriage rates of group B streptococci among 250 women attending a clinic for sexually transmitted diseases, 123 attending family planning clinics, and 110 in labour wages were 36.0%, 17-1% and 6.4% respectively. The presence of group B streptococci was not associated with a vaginal discharge or the use of oral contraceptives in the non-pregnant women, or with the isolation of Neisseria gonorrhoeae or Trichomonas vaginalis from the women attending the clinic for sexually transmitted diseases. Serotyping showed a predominance of types II and III in non-pregnant women and an overall incidence of non-typable strains of 14.8%. There was no relationship between serotype and antibacterial susceptibility.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002353:Carrier State; D003276:Contraceptives, Oral; D005260:Female; D006801:Humans; D007743:Labor, Obstetric; D007973:Leukorrhea / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D011247:Pregnancy; D012749:Sexually Transmitted Diseases / Q000150:complications; D013292:Streptococcus agalactiae / Q000187:drug effects / Q000302:isolation & purification*; D013420:Sulfamethoxazole / Q000494:pharmacology; D014246:Trichomonas vaginalis / Q000302:isolation & purification; D014295:Trimethoprim / Q000494:pharmacology; D014621:Vagina / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D003276:Contraceptives, Oral; D014295:Trimethoprim; D013420:Sulfamethoxazole